Brief: Remus Pharmaceuticals Approved In Principle To Incorporate 2 Subsidiaries And 2 Wholly Owned Subsidiaries Outside India
04/08/2023 13:05
Aug 4 (Reuters) - Remus Pharmaceuticals Ltd REMP.NS :
* APPROVED IN PRINCIPLE TO INCORPORATE 2 SUBSIDIARIES AND 2
WHOLLY
OWNED SUBSIDIARIES OUTSIDE INDIA
Source text for Eikon: ID:nNSE527SYr
Further company coverage: REMP.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Remus Pharmaceuticals
See all newsBrief: Remus Pharmaceuticals Re-Appoints Arpit Shah As MD
Brief: Remus Pharmaceuticals Incorporates Subsidiary For Clinical Trial Material Management
Brief: Remus Pharmaceuticals Acquiring Membership Interest Of 56.67% In Espee Global Holdings
Brief: Remus Pharmaceuticals To Sell Entire Stake In Unit Ratnatris Pharmaceuticals Via Shares Swap
Brief: Remus Pharmaceuticals To Make Strategic Investment In Espee Biopharma & Finechem LLC